Fig. 2

The genetic features of CD79B and PIM1 mutations and their association with survival. (a) Complex genetic events were involved in the CD79B and PIM1 mutations. (b) PIM1- (n = 36, p = 0.004) and CD79B-mutant (n = 30, p = 0.000) patients had poorer PFS than wild-type patients. CD79B-mutant patients displayed poorer OS (n = 30, p = 0.001), while those with PIM1 mutation were indifferent (n = 36, p = 0.862). (c) PIM1- (n = 166, p = 0.002) and CD79B-mutant (n = 47, p = 0.028) patients were validated to have worse OS in a larger DLBCL cohort